2015
DOI: 10.1093/ofid/ofv133.1265
|View full text |Cite
|
Sign up to set email alerts
|

Reducing Clostridium difficile Infection Among Hematology-Oncology Patients Using Ultraviolet Germicidal Irradiation for Terminal Room Disinfection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
0

Year Published

2016
2016
2017
2017

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Multiple clinical trials have assessed the efficacy of UV or hydrogen peroxide room decontamination units for reducing HAIs (Table 4). 56,[65][66][67][68][69][70][71][72][73][74] Several studies warrant detailed discussion, including the studies by Passaretti et al, 67 Pegues et al, 73 and Anderson et al 74 Passaretti et al performed a 30-month prospective cohort (before-after study) intervention using a hydrogen peroxide vapor device (Bioquell) on 6 high-risk units in a 994-bed tertiary care hospital. 67 Patients admitted to rooms decontaminated using HPV were 64% less likely to acquire any multidrug-resistant pathogen (IRR, 0.36; P < .001) and 80% less likely to acquire VRE (IRR, 0.20; P < .001).…”
Section: Clinical Trials Using Hpv Room Decontamination Devicesmentioning
confidence: 99%
See 1 more Smart Citation
“…Multiple clinical trials have assessed the efficacy of UV or hydrogen peroxide room decontamination units for reducing HAIs (Table 4). 56,[65][66][67][68][69][70][71][72][73][74] Several studies warrant detailed discussion, including the studies by Passaretti et al, 67 Pegues et al, 73 and Anderson et al 74 Passaretti et al performed a 30-month prospective cohort (before-after study) intervention using a hydrogen peroxide vapor device (Bioquell) on 6 high-risk units in a 994-bed tertiary care hospital. 67 Patients admitted to rooms decontaminated using HPV were 64% less likely to acquire any multidrug-resistant pathogen (IRR, 0.36; P < .001) and 80% less likely to acquire VRE (IRR, 0.20; P < .001).…”
Section: Clinical Trials Using Hpv Room Decontamination Devicesmentioning
confidence: 99%
“…Pegues et al performed a prospective cohort (before-after study) in 3 hematology-oncology units to assess the efficacy of a UV-C device (Optimum) to reduce C difficile infection. 73 Importantly, rooms were disinfected with bleach prior to use of the UV-C device. A significant association between UV-C use and a decline in C difficile infection incidence was noted on study units (IRR, 0.49; 95% confidence interval, 0.26-0.94; P = .03) but not on the nonstudy units (IRR, 0.63; 95% confidence interval, 0.38-1.06; P = .08).…”
Section: Clinical Trials Using Hpv Room Decontamination Devicesmentioning
confidence: 99%
“…Several studies warrant detailed discussion, including the studies by Passaretti et al [53], by Pegues et al [47], and by Anderson et al [46]. Passaretti et al [53] performed a 30-month prospective cohort (before-after study that was strengthened by the use of concurrent controls) intervention using a HPV device on six high-risk units in a 994-bed Pegues et al [47] performed a prospective cohort (before-after study) in three haematology-oncology units to assess the efficacy of a UV-C device to reduce C. difficile infections (CDIs). Importantly, rooms were disinfected with bleach prior to use of the device.…”
Section: Clinical Trials Using 'No Touch' Room Decontamination Methodsmentioning
confidence: 99%
“…Moreover, they reduce microbial contamination substantially [69•, 70•] and they have been used to control outbreaks in healthcare facilities [69•]. Studies to date have demonstrated that hydrogen peroxide vapor significantly decreased acquisition of any multidrug-resistant organism [74•], that UV-C use was associated with a significantly decreased incidence of C. difficile infections [75], and that terminal room decontamination enhanced with both bleach and UV-C light significantly decreased the risk of acquiring a target organism (i.e., MRSA, VRE, or C. difficile multidrug-resistant Acinetobacter) [45]. However, these technologies are expensive and they increase the time needed for terminal room disinfection.…”
Section: Technology Use In Infection Prevention and Controlmentioning
confidence: 99%